Evidence map›Paper›PMID 34306344›Full record

ArticleAmerican journal of translational research2021

EGFR/EGFRvIII partly regulates the tumourigenesis of glioblastoma through the SOX9-GLUT3 axis.

Shenbo Chen, Liangwang Yang, Zhengzheng Li, Shenghua Zhuo, Bo Yan, Zhaoteng Zhang, Jinben Zhang, Haizhong Feng, Kun Yang

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Comprehensive Analysis of the Role ofAnalytical cellular pathology (Amsterdam) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shenbo ChenDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Liangwang YangDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Zhengzheng LiDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Shenghua ZhuoDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Bo YanDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Zhaoteng ZhangDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Jinben ZhangDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
Haizhong FengState Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai 200127, China.
Kun YangDepartment of Neurosurgery, The Affiliated Hospital of Hainan Medical College Haikou 570102, Hainan, China.
State Key Laboratory of Oncogene and Related Genes · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EGFR/EGFR variant III (EGFRvIII) glioblastoma is seriously malignant, and the underlying mechanism remains unclear. In this study, EGFR and GLUT3 were found to be co-expressed in our collected tissues and associated with worse overall survival in glioblastoma via bioinformatics analysis. Functionally,

Indexed as

EGFREGFRvIIIglioblastomaGLUT3SOX9

Identifiers

PMID34306344
PMCPMC8290802
OpenAlexW3183924509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.